Log in

NYSEAMERICAN:INFUInfuSystem Stock Price, Forecast & News

$10.61
-0.60 (-5.35 %)
(As of 07/2/2020 04:00 PM ET)
Add
Compare
Today's Range
$10.45
Now: $10.61
$11.44
50-Day Range N/A
52-Week Range
$4.28
Now: $10.61
$13.25
Volume112,086 shs
Average Volume105,102 shs
Market Capitalization$212.94 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
InfuSystem Holdings Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole mounted and ambulatory infusion pumps; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. InfuSystem Holdings Inc. was founded in 2005 and is headquartered in Madison Heights, Michigan.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.16 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:INFU
CUSIPN/A
Phone+1-248-2911210

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees237
Market Cap$212.94 million
Next Earnings Date8/12/2020 (Estimated)
OptionableNot Optionable

Receive INFU News and Ratings via Email

Sign-up to receive the latest news and ratings for INFU and its competitors with MarketBeat's FREE daily newsletter.

InfuSystem (NYSEAMERICAN:INFU) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of InfuSystem?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InfuSystem in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for InfuSystem.

When is InfuSystem's next earnings date?

InfuSystem is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for InfuSystem.

How were InfuSystem's earnings last quarter?

InfuSystem Holdings Inc (NYSEAMERICAN:INFU) announced its quarterly earnings results on Thursday, May, 14th. The medical instruments supplier reported ($0.02) EPS for the quarter. The medical instruments supplier earned $21.55 million during the quarter. View InfuSystem's earnings history.

What price target have analysts set for INFU?

1 Wall Street analysts have issued 12-month price objectives for InfuSystem's stock. Their forecasts range from $17.00 to $17.00. On average, they expect InfuSystem's share price to reach $17.00 in the next twelve months. This suggests a possible upside of 60.2% from the stock's current price. View analysts' price targets for InfuSystem.

Has InfuSystem been receiving favorable news coverage?

News headlines about INFU stock have trended somewhat negative recently, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. InfuSystem earned a daily sentiment score of -1.0 on InfoTrie's scale. They also gave headlines about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news about InfuSystem.

Are investors shorting InfuSystem?

InfuSystem saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 159,400 shares, an increase of 33.3% from the May 31st total of 119,600 shares. Based on an average trading volume of 81,600 shares, the short-interest ratio is presently 2.0 days. Approximately 0.9% of the company's shares are short sold. View InfuSystem's Current Options Chain.

Who are some of InfuSystem's key competitors?

What other stocks do shareholders of InfuSystem own?

Who are InfuSystem's key executives?

InfuSystem's management team includes the following people:
  • Mr. Richard A. DiIorio, Pres, CEO & Director (Age 44)
  • Mr. Gregory Schulte, Exec. VP & CFO (Age 52)
  • Mr. Thomas Mark Ruiz, Sr. VP of Sales & Marketing
  • Mr. John Haggerty, Sr. VP of Biomedical Services & Logistics
  • Ms. Jean Pfeiffer, Sr. VP of Strategic Initiatives

What is InfuSystem's stock symbol?

InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU."

How do I buy shares of InfuSystem?

Shares of INFU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is InfuSystem's stock price today?

One share of INFU stock can currently be purchased for approximately $10.61.

How big of a company is InfuSystem?

InfuSystem has a market capitalization of $212.94 million. InfuSystem employs 237 workers across the globe.

What is InfuSystem's official website?

The official website for InfuSystem is ir.infusystem.com.

How can I contact InfuSystem?

InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The medical instruments supplier can be reached via phone at +1-248-2911210.

This page was last updated on 7/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.